MEDTRONIC PLC (2M6.DE) Fundamental Analysis & Valuation

FRA:2M6IE00BTN1Y115

Current stock price

70.92 EUR
-0.28 (-0.39%)
Last:

This 2M6.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. 2M6.DE Profitability Analysis

1.1 Basic Checks

  • In the past year 2M6 was profitable.
  • 2M6 had a positive operating cash flow in the past year.
  • Each year in the past 5 years 2M6 has been profitable.
  • 2M6 had a positive operating cash flow in each of the past 5 years.
2M6.DE Yearly Net Income VS EBIT VS OCF VS FCF2M6.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • With a decent Return On Assets value of 5.04%, 2M6 is doing good in the industry, outperforming 68.85% of the companies in the same industry.
  • With a decent Return On Equity value of 9.42%, 2M6 is doing good in the industry, outperforming 65.57% of the companies in the same industry.
  • 2M6 has a Return On Invested Capital of 6.57%. This is comparable to the rest of the industry: 2M6 outperforms 55.74% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 2M6 is below the industry average of 10.31%.
  • The 3 year average ROIC (6.35%) for 2M6 is below the current ROIC(6.57%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.04%
ROE 9.42%
ROIC 6.57%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
2M6.DE Yearly ROA, ROE, ROIC2M6.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

  • With an excellent Profit Margin value of 13.00%, 2M6 belongs to the best of the industry, outperforming 80.33% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 2M6 has declined.
  • With an excellent Operating Margin value of 18.98%, 2M6 belongs to the best of the industry, outperforming 80.33% of the companies in the same industry.
  • 2M6's Operating Margin has been stable in the last couple of years.
  • 2M6 has a Gross Margin of 65.16%. This is in the better half of the industry: 2M6 outperforms 70.49% of its industry peers.
  • 2M6's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.98%
PM (TTM) 13%
GM 65.16%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
2M6.DE Yearly Profit, Operating, Gross Margins2M6.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. 2M6.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 2M6 is creating some value.
  • Compared to 1 year ago, 2M6 has less shares outstanding
  • 2M6 has less shares outstanding than it did 5 years ago.
  • 2M6 has a worse debt/assets ratio than last year.
2M6.DE Yearly Shares Outstanding2M6.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
2M6.DE Yearly Total Debt VS Total Assets2M6.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • An Altman-Z score of 2.83 indicates that 2M6 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.83, 2M6 is in line with its industry, outperforming 52.46% of the companies in the same industry.
  • 2M6 has a debt to FCF ratio of 5.19. This is a neutral value as 2M6 would need 5.19 years to pay back of all of its debts.
  • 2M6 has a Debt to FCF ratio of 5.19. This is comparable to the rest of the industry: 2M6 outperforms 54.10% of its industry peers.
  • A Debt/Equity ratio of 0.57 indicates that 2M6 is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.57, 2M6 is doing worse than 63.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.19
Altman-Z 2.83
ROIC/WACC1.02
WACC6.45%
2M6.DE Yearly LT Debt VS Equity VS FCF2M6.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • 2M6 has a Current Ratio of 2.54. This indicates that 2M6 is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.54, 2M6 is in the better half of the industry, outperforming 72.13% of the companies in the same industry.
  • A Quick Ratio of 1.87 indicates that 2M6 should not have too much problems paying its short term obligations.
  • The Quick ratio of 2M6 (1.87) is better than 77.05% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 1.87
2M6.DE Yearly Current Assets VS Current Liabilites2M6.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

4

3. 2M6.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.87% over the past year.
  • The Earnings Per Share has been growing slightly by 3.68% on average over the past years.
  • The Revenue has been growing slightly by 6.88% in the past year.
  • The Revenue has been growing slightly by 3.01% on average over the past years.
EPS 1Y (TTM)4.87%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%-2.16%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%8.74%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.10% on average over the next years.
  • The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y2.83%
EPS Next 2Y5.59%
EPS Next 3Y6.24%
EPS Next 5Y7.1%
Revenue Next Year7.95%
Revenue Next 2Y7.24%
Revenue Next 3Y6.44%
Revenue Next 5Y6.02%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
2M6.DE Yearly Revenue VS Estimates2M6.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
2M6.DE Yearly EPS VS Estimates2M6.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

5

4. 2M6.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • 2M6 is valuated correctly with a Price/Earnings ratio of 14.81.
  • Based on the Price/Earnings ratio, 2M6 is valued cheaper than 93.44% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.42. 2M6 is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 13.52, the valuation of 2M6 can be described as correct.
  • 2M6's Price/Forward Earnings ratio is rather cheap when compared to the industry. 2M6 is cheaper than 81.97% of the companies in the same industry.
  • 2M6's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.24.
Industry RankSector Rank
PE 14.81
Fwd PE 13.52
2M6.DE Price Earnings VS Forward Price Earnings2M6.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 65.57% of the companies in the same industry are more expensive than 2M6, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, 2M6 is valued a bit cheaper than 73.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.69
EV/EBITDA 12.16
2M6.DE Per share data2M6.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 2M6 does not grow enough to justify the current Price/Earnings ratio.
  • 2M6 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.23
PEG (5Y)4.02
EPS Next 2Y5.59%
EPS Next 3Y6.24%

6

5. 2M6.DE Dividend Analysis

5.1 Amount

  • 2M6 has a Yearly Dividend Yield of 3.32%.
  • Compared to an average industry Dividend Yield of 1.26, 2M6 pays a better dividend. On top of this 2M6 pays more dividend than 91.80% of the companies listed in the same industry.
  • 2M6's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.32%

5.2 History

  • The dividend of 2M6 has a limited annual growth rate of 5.10%.
Dividend Growth(5Y)5.1%
Div Incr Years8
Div Non Decr Years8
2M6.DE Yearly Dividends per share2M6.DE Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 2M6 pays out 78.65% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of 2M6 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP78.65%
EPS Next 2Y5.59%
EPS Next 3Y6.24%
2M6.DE Yearly Income VS Free CF VS Dividend2M6.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
2M6.DE Dividend Payout.2M6.DE Dividend Payout, showing the Payout Ratio.2M6.DE Dividend Payout.PayoutRetained Earnings

2M6.DE Fundamentals: All Metrics, Ratios and Statistics

MEDTRONIC PLC

FRA:2M6 (4/24/2026, 7:00:00 PM)

70.92

-0.28 (-0.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17
Earnings (Next)06-03
Inst Owners87.92%
Inst Owner ChangeN/A
Ins Owners0.28%
Ins Owner ChangeN/A
Market Cap91.05B
Revenue(TTM)35.48B
Net Income(TTM)4.61B
Analysts76.22
Price Target94.6 (33.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.32%
Yearly Dividend2.35
Dividend Growth(5Y)5.1%
DP78.65%
Div Incr Years8
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.66%
Min EPS beat(2)0.89%
Max EPS beat(2)2.43%
EPS beat(4)4
Avg EPS beat(4)1.6%
Min EPS beat(4)0.89%
Max EPS beat(4)2.43%
EPS beat(8)6
Avg EPS beat(8)1.11%
EPS beat(12)9
Avg EPS beat(12)1.9%
EPS beat(16)11
Avg EPS beat(16)1.33%
Revenue beat(2)2
Avg Revenue beat(2)0.17%
Min Revenue beat(2)0.08%
Max Revenue beat(2)0.26%
Revenue beat(4)4
Avg Revenue beat(4)0.35%
Min Revenue beat(4)0.08%
Max Revenue beat(4)0.91%
Revenue beat(8)7
Avg Revenue beat(8)0.23%
Revenue beat(12)10
Avg Revenue beat(12)0.48%
Revenue beat(16)12
Avg Revenue beat(16)0.07%
PT rev (1m)-1.36%
PT rev (3m)-0.57%
EPS NQ rev (1m)-3.45%
EPS NQ rev (3m)-5.15%
EPS NY rev (1m)-0.7%
EPS NY rev (3m)-0.78%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.26%
Valuation
Industry RankSector Rank
PE 14.81
Fwd PE 13.52
P/S 3
P/FCF 19.69
P/OCF 14.62
P/B 2.17
P/tB N/A
EV/EBITDA 12.16
EPS(TTM)4.79
EY6.75%
EPS(NY)5.24
Fwd EY7.39%
FCF(TTM)3.6
FCFY5.08%
OCF(TTM)4.85
OCFY6.84%
SpS23.63
BVpS32.63
TBVpS-2.16
PEG (NY)5.23
PEG (5Y)4.02
Graham Number59.2989 (-16.39%)
Profitability
Industry RankSector Rank
ROA 5.04%
ROE 9.42%
ROCE 8.21%
ROIC 6.57%
ROICexc 7.32%
ROICexgc 25.19%
OM 18.98%
PM (TTM) 13%
GM 65.16%
FCFM 15.24%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.19
Debt/EBITDA 2.84
Cap/Depr 60.84%
Cap/Sales 5.28%
Interest Coverage 8.77
Cash Conversion 74.21%
Profit Quality 117.26%
Current Ratio 2.54
Quick Ratio 1.87
Altman-Z 2.83
F-Score7
WACC6.45%
ROIC/WACC1.02
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)4.87%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%-2.16%
EPS Next Y2.83%
EPS Next 2Y5.59%
EPS Next 3Y6.24%
EPS Next 5Y7.1%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%8.74%
Revenue Next Year7.95%
Revenue Next 2Y7.24%
Revenue Next 3Y6.44%
Revenue Next 5Y6.02%
EBIT growth 1Y4.15%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year18.42%
EBIT Next 3Y11.24%
EBIT Next 5Y9.86%
FCF growth 1Y9.67%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y12.56%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%

MEDTRONIC PLC / 2M6.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MEDTRONIC PLC (2M6.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 2M6.DE.


What is the valuation status for 2M6 stock?

ChartMill assigns a valuation rating of 5 / 10 to MEDTRONIC PLC (2M6.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for MEDTRONIC PLC?

MEDTRONIC PLC (2M6.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for 2M6 stock?

The Price/Earnings (PE) ratio for MEDTRONIC PLC (2M6.DE) is 14.81 and the Price/Book (PB) ratio is 2.17.


Can you provide the financial health for 2M6 stock?

The financial health rating of MEDTRONIC PLC (2M6.DE) is 5 / 10.